bioAffinity Technologies, Inc. (BIAF)
NASDAQ: BIAF · IEX Real-Time Price · USD
2.400
-0.020 (-0.83%)
At close: May 31, 2024, 4:00 PM
2.330
-0.070 (-2.92%)
After-hours: May 31, 2024, 6:40 PM EDT
bioAffinity Technologies Market Cap
bioAffinity Technologies has a market cap or net worth of $27.98 million as of May 31, 2024. Its market cap has increased by 82.86% in one year.
Market Cap
27.98M
Enterprise Value
27.02M
1-Year Change
82.86%
Ranking
Category
Stock Price
$2.40
Market Cap Chart
Since the IPO on September 1, 2022, bioAffinity Technologies's market cap has decreased from $44.99M to $27.98M, a decrease of -37.82%. That is a compound annual growth rate of -23.80%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
May 31, 2024 | 28.00M | -0.71% |
May 30, 2024 | 28.20M | -1.40% |
May 29, 2024 | 28.60M | -3.38% |
May 28, 2024 | 29.60M | -4.82% |
May 24, 2024 | 31.10M | 8.36% |
May 23, 2024 | 28.70M | -0.69% |
May 22, 2024 | 28.90M | 4.71% |
May 21, 2024 | 27.60M | 6.56% |
May 20, 2024 | 25.90M | -1.52% |
May 17, 2024 | 26.30M | -8.04% |
May 16, 2024 | 28.60M | 30.59% |
May 15, 2024 | 21.90M | 1.86% |
May 14, 2024 | 21.50M | -6.11% |
May 13, 2024 | 22.90M | -0.43% |
May 10, 2024 | 23.00M | -1.29% |
May 9, 2024 | 23.30M | -2.10% |
May 8, 2024 | 23.80M | -0.42% |
May 7, 2024 | 23.90M | 5.29% |
May 6, 2024 | 22.70M | -5.81% |
May 3, 2024 | 24.10M | -8.71% |
May 2, 2024 | 26.40M | -6.38% |
May 1, 2024 | 28.20M | - |
Apr 30, 2024 | 28.20M | -3.09% |
Apr 29, 2024 | 29.10M | 6.59% |
Apr 26, 2024 | 27.30M | -1.44% |
View and export this data all the way back to 2022.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Bolt Biotherapeutics | 28.85M |
Qilian International Holding Group | 28.60M |
NanoViricides | 28.59M |
Enlivex Therapeutics | 28.10M |
SeaStar Medical Holding | 28.01M |
BiomX | 27.92M |
BioVie | 27.79M |
RenovoRx | 27.78M |